{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:14:33Z","timestamp":1790709273363,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"national Institute of health","award":["DK102032"],"award-info":[{"award-number":["DK102032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00401-024-02710-4","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T09:01:59Z","timestamp":1711357319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A muscarinic receptor antagonist reverses multiple indices of diabetic peripheral neuropathy: preclinical and clinical studies using oxybutynin"],"prefix":"10.1007","volume":"147","clinical-trial-number":[{"clinical-trial-number":"nct03050827","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Carolina M.","family":"Casselini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri K.","family":"Parson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie E.","family":"Frizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Guernsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Nemmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Tayarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4391-1341","authenticated-orcid":false,"given":"Corinne G.","family":"Jolivalt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Fernyhough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron I.","family":"Vinik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel A.","family":"Calcutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,25]]},"reference":[{"key":"2710_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.998904","volume":"13","author":"P Anand","year":"2022","unstructured":"Anand P, Privitera R, Donatien P, Fadavi H, Tesfaye S, Bravis V et al (2022) Reversing painful and non-painful diabetic neuropathy with the capsaicin 8% patch: clinical evidence for pain relief and restoration of function via nerve fiber regeneration. Front Neurol 13:998904. https:\/\/doi.org\/10.3389\/fneur.2022.998904","journal-title":"Front Neurol"},{"key":"2710_CR2","doi-asserted-by":"publisher","first-page":"696","DOI":"10.4065\/78.6.696","volume":"78","author":"RA Appell","year":"2003","unstructured":"Appell RA, Chancellor MB, Zobrist RH, Thomas H, Sanders SW (2003) Pharmacokinetics, metabolism, and saliva output during transdermal and extended-release oral oxybutynin administration in healthy subjects. Mayo Clin Proc 78:696\u2013702. https:\/\/doi.org\/10.4065\/78.6.696","journal-title":"Mayo Clin Proc"},{"key":"2710_CR3","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1007\/s00125-019-4897-y","volume":"62","author":"S Azmi","year":"2019","unstructured":"Azmi S, Jeziorska M, Ferdousi M, Petropoulos IN, Ponirakis G, Marshall A et al (2019) Early nerve fibre regeneration in individuals with type 1 diabetes after simultaneous pancreas and kidney transplantation. Diabetologia 62:1478\u20131487. https:\/\/doi.org\/10.1007\/s00125-019-4897-y","journal-title":"Diabetologia"},{"key":"2710_CR4","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.clinthera.2005.08.002","volume":"27","author":"EJ Bastyr 3rd","year":"2005","unstructured":"Bastyr EJ 3rd, Price KL, Bril V, Group MS (2005) Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clin Ther 27:1278\u20131294. https:\/\/doi.org\/10.1016\/j.clinthera.2005.08.002","journal-title":"Clin Ther"},{"key":"2710_CR5","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1177\/193229681100500326","volume":"5","author":"A Boyd","year":"2011","unstructured":"Boyd A, Casselini C, Vinik E, Vinik A (2011) Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate. J Diabetes Sci Technol 5:714\u2013722. https:\/\/doi.org\/10.1177\/193229681100500326","journal-title":"J Diabetes Sci Technol"},{"key":"2710_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2147\/DMSOTT.S13699","volume":"3","author":"AL Boyd","year":"2010","unstructured":"Boyd AL, Barlow PM, Pittenger GL, Simmons KF, Vinik AI (2010) Topiramate improves neurovascular function, epidermal nerve fiber morphology, and metabolism in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes 3:431\u2013437. https:\/\/doi.org\/10.2147\/DMSOTT.S13699","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"Suppl 1","key":"2710_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000052074","volume":"41","author":"V Bril","year":"1999","unstructured":"Bril V (1999) NIS-LL: the primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy. Eur Neurol 41(Suppl 1):8\u201313. https:\/\/doi.org\/10.1159\/000052074","journal-title":"Eur Neurol"},{"key":"2710_CR8","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1172\/JCI88321","volume":"127","author":"NA Calcutt","year":"2017","unstructured":"Calcutt NA, Smith DR, Frizzi K, Sabbir MG, Chowdhury SK, Mixcoatl-Zecuatl T et al (2017) Selective antagonism of muscarinic receptors is neuroprotective in peripheral neuropathy. J Clin Invest 127:608\u2013622. https:\/\/doi.org\/10.1172\/JCI88321","journal-title":"J Clin Invest"},{"key":"2710_CR9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.2337\/dc06-1699","volume":"30","author":"CM Casellini","year":"2007","unstructured":"Casellini CM, Barlow PM, Rice AL, Casey M, Simmons K, Pittenger G et al (2007) A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy. Diabetes Care 30:896\u2013902. https:\/\/doi.org\/10.2337\/dc06-1699","journal-title":"Diabetes Care"},{"key":"2710_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154211","volume":"11","author":"CM Casellini","year":"2016","unstructured":"Casellini CM, Parson HK, Hodges K, Edwards JF, Lieb DC, Wohlgemuth SD et al (2016) Bariatric surgery restores cardiac and sudomotor autonomic C-fiber dysfunction towards normal in obese subjects with type 2 diabetes. PLoS ONE 11:e0154211. https:\/\/doi.org\/10.1371\/journal.pone.0154211","journal-title":"PLoS ONE"},{"key":"2710_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40478-019-0657-y","volume":"7","author":"O Cerles","year":"2019","unstructured":"Cerles O, Goncalves TC, Chouzenoux S, Benoit E, Schmitt A, Bennett Saidu NE et al (2019) Preventive action of benztropine on platinum-induced peripheral neuropathies and tumor growth. Acta Neuropathol Commun 7:9. https:\/\/doi.org\/10.1186\/s40478-019-0657-y","journal-title":"Acta Neuropathol Commun"},{"key":"2710_CR12","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41598-021-81302-8","volume":"11","author":"S Dhage","year":"2021","unstructured":"Dhage S, Ferdousi M, Adam S, Ho JH, Kalteniece A, Azmi S et al (2021) Corneal confocal microscopy identifies small fibre damage and progression of diabetic neuropathy. Sci Rep 11:1859. https:\/\/doi.org\/10.1038\/s41598-021-81302-8","journal-title":"Sci Rep"},{"key":"2710_CR13","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1007\/s00192-021-04909-5","volume":"32","author":"V Duong","year":"2021","unstructured":"Duong V, Iwamoto A, Pennycuff J, Kudish B, Iglesia C (2021) A systematic review of neurocognitive dysfunction with overactive bladder medications. Int Urogynecol J 32:2693\u20132702. https:\/\/doi.org\/10.1007\/s00192-021-04909-5","journal-title":"Int Urogynecol J"},{"key":"2710_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/ane.13171","volume":"141","author":"L Ekman","year":"2020","unstructured":"Ekman L, Thrainsdottir S, Englund E, Thomsen N, Rosen I, Hazer Rosberg DB et al (2020) Evaluation of small nerve fiber dysfunction in type 2 diabetes. Acta Neurol Scand 141:38\u201346. https:\/\/doi.org\/10.1111\/ane.13171","journal-title":"Acta Neurol Scand"},{"key":"2710_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/bs.irn.2016.03.001","volume":"127","author":"SM Emery","year":"2016","unstructured":"Emery SM, Dobrowsky RT (2016) Promoting neuronal tolerance of diabetic stress: modulating molecular chaperones. Int Rev Neurobiol 127:181\u2013210. https:\/\/doi.org\/10.1016\/bs.irn.2016.03.001","journal-title":"Int Rev Neurobiol"},{"key":"2710_CR16","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/j.pain.2011.07.005","volume":"152","author":"MA Ferreira-Valente","year":"2011","unstructured":"Ferreira-Valente MA, Pais-Ribeiro JL, Jensen MP (2011) Validity of four pain intensity rating scales. Pain 152:2399\u20132404. https:\/\/doi.org\/10.1016\/j.pain.2011.07.005","journal-title":"Pain"},{"key":"2710_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/mus.21626","volume":"42","author":"CH Gibbons","year":"2010","unstructured":"Gibbons CH, Illigens BM, Wang N, Freeman R (2010) Quantification of sudomotor innervation: a comparison of three methods. Muscle Nerve 42:112\u2013119. https:\/\/doi.org\/10.1002\/mus.21626","journal-title":"Muscle Nerve"},{"key":"2710_CR18","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/jns.12457","volume":"26","author":"CH Gibbons","year":"2021","unstructured":"Gibbons CH, Zhu J, Zhang X, Habboubi N, Hariri R, Veves A (2021) Phase 2a randomized controlled study investigating the safety and efficacy of PDA-002 in diabetic peripheral neuropathy. J Peripher Nerv Syst 26:276\u2013289. https:\/\/doi.org\/10.1111\/jns.12457","journal-title":"J Peripher Nerv Syst"},{"key":"2710_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrneurol.2016.201","volume":"13","author":"NP Goncalves","year":"2017","unstructured":"Goncalves NP, Vaegter CB, Andersen H, Ostergaard L, Calcutt NA, Jensen TS (2017) Schwann cell interactions with axons and microvessels in diabetic neuropathy. Nat Rev Neurol 13:135\u2013147. https:\/\/doi.org\/10.1038\/nrneurol.2016.201","journal-title":"Nat Rev Neurol"},{"key":"2710_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.663373","volume":"12","author":"MM Han","year":"2021","unstructured":"Han MM, Frizzi KE, Ellis RJ, Calcutt NA, Fields JA (2021) Prevention of HIV-1 TAT protein-induced peripheral neuropathy and mitochondrial disruption by the antimuscarinic pirenzepine. Front Neurol 12:663373. https:\/\/doi.org\/10.3389\/fneur.2021.663373","journal-title":"Front Neurol"},{"key":"2710_CR21","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.jdiacomp.2015.07.013","volume":"29","author":"M Jaiswal","year":"2015","unstructured":"Jaiswal M, Martin CL, Brown MB, Callaghan B, Albers JW, Feldman EL et al (2015) Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study. J Diabetes Complicat 29:1287\u20131294. https:\/\/doi.org\/10.1016\/j.jdiacomp.2015.07.013","journal-title":"J Diabetes Complicat"},{"key":"2710_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/cpmo.11","volume":"6","author":"CG Jolivalt","year":"2016","unstructured":"Jolivalt CG, Frizzi KE, Guernsey L, Marquez A, Ochoa J, Rodriguez M et al (2016) Peripheral neuropathy in mouse models of diabetes. Curr Protoc Mouse Biol 6:223\u2013255. https:\/\/doi.org\/10.1002\/cpmo.11","journal-title":"Curr Protoc Mouse Biol"},{"key":"2710_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1124\/jpet.120.265447","volume":"374","author":"CG Jolivalt","year":"2020","unstructured":"Jolivalt CG, Frizzi KE, Han MM, Mota AJ, Guernsey LS, Kotra LP et al (2020) Topical delivery of muscarinic receptor antagonists prevents and reverses peripheral neuropathy in female diabetic mice. J Pharmacol Exp Ther 374:44\u201351. https:\/\/doi.org\/10.1124\/jpet.120.265447","journal-title":"J Pharmacol Exp Ther"},{"key":"2710_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092307","author":"CG Jolivalt","year":"2022","unstructured":"Jolivalt CG, Han MM, Nguyen A, Desmond F, Alves Jesus CH, Vasconselos DC et al (2022) Using corneal confocal microscopy to identify therapeutic agents for diabetic neuropathy. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11092307","journal-title":"J Clin Med"},{"key":"2710_CR25","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jdiacomp.2012.05.007","volume":"26","author":"PM Kluding","year":"2012","unstructured":"Kluding PM, Pasnoor M, Singh R, Jernigan S, Farmer K, Rucker J et al (2012) The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabetes Complicat 26:424\u2013429. https:\/\/doi.org\/10.1016\/j.jdiacomp.2012.05.007","journal-title":"J Diabetes Complicat"},{"key":"2710_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/jns.12392","volume":"25","author":"M Kobayashi","year":"2020","unstructured":"Kobayashi M, Zochodne DW (2020) Diabetic polyneuropathy: Bridging the translational gap. J Peripher Nerv Syst 25:66\u201375. https:\/\/doi.org\/10.1111\/jns.12392","journal-title":"J Peripher Nerv Syst"},{"key":"2710_CR27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1529-8027.2010.00271.x","volume":"15","author":"G Lauria","year":"2010","unstructured":"Lauria G, Bakkers M, Schmitz C, Lombardi R, Penza P, Devigili G et al (2010) Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst 15:202\u2013207. https:\/\/doi.org\/10.1111\/j.1529-8027.2010.00271.x","journal-title":"J Peripher Nerv Syst"},{"key":"2710_CR28","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/j.1468-1331.2010.03023.x","volume":"17","author":"G Lauria","year":"2010","unstructured":"Lauria G, Hsieh ST, Johansson O, Kennedy WR, Leger JM, Mellgren SI et al (2010) European federation of neurological societies\/peripheral nerve society guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy: report of a joint task force of the European federation of neurological societies and the peripheral nerve society. Eur J Neurol 17:903\u2013912. https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03023.x","journal-title":"Eur J Neurol"},{"key":"2710_CR29","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1517\/17425255.2012.714365","volume":"8","author":"U Leone Roberti Maggiore","year":"2012","unstructured":"Leone Roberti Maggiore U, Salvatore S, Alessandri F, Remorgida V, Origoni M, Candiani M et al (2012) Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females. Expert Opin Drug Metab Toxicol 8:1387\u20131408. https:\/\/doi.org\/10.1517\/17425255.2012.714365","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2710_CR30","first-page":"1","volume":"11","author":"SA Macdiarmid","year":"2009","unstructured":"Macdiarmid SA (2009) The evolution of transdermal\/topical overactive bladder therapy and its benefits over oral therapy. Rev Urol 11:1\u20136","journal-title":"Rev Urol"},{"key":"2710_CR31","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s00125-004-1663-5","volume":"48","author":"RA Malik","year":"2005","unstructured":"Malik RA, Tesfaye S, Newrick PG, Walker D, Rajbhandari SM, Siddique I et al (2005) Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 48:578\u2013585. https:\/\/doi.org\/10.1007\/s00125-004-1663-5","journal-title":"Diabetologia"},{"key":"2710_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2004.07.017","volume":"111","author":"AB Malmberg","year":"2004","unstructured":"Malmberg AB, Mizisin AP, Calcutt NA, von Stein T, Robbins WR, Bley KR (2004) Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch. Pain 111:360\u2013367. https:\/\/doi.org\/10.1016\/j.pain.2004.07.017","journal-title":"Pain"},{"key":"2710_CR33","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.2337\/db16-1181","volume":"66","author":"AG Marshall","year":"2017","unstructured":"Marshall AG, Lee-Kubli C, Azmi S, Zhang M, Ferdousi M, Mixcoatl-Zecuatl T et al (2017) Spinal disinhibition in experimental and clinical painful diabetic neuropathy. Diabetes 66:1380\u20131390. https:\/\/doi.org\/10.2337\/db16-1181","journal-title":"Diabetes"},{"key":"2710_CR34","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1248\/bpb.b18-00690","volume":"42","author":"Y Murakami","year":"2019","unstructured":"Murakami Y, Sekijima H, Fujisawa Y, Ooi K (2019) Adjustment of conditions for combining oxybutynin transdermal patch with heparinoid cream in mice by analyzing blood concentrations of oxybutynin hydrochloride. Biol Pharm Bull 42:586\u2013593. https:\/\/doi.org\/10.1248\/bpb.b18-00690","journal-title":"Biol Pharm Bull"},{"key":"2710_CR35","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.2337\/dc21-0476","volume":"44","author":"BA Perkins","year":"2021","unstructured":"Perkins BA, Lovblom LE, Lewis EJH, Bril V, Ferdousi M, Orszag A et al (2021) Corneal Confocal microscopy predicts the development of diabetic neuropathy: a longitudinal diagnostic multinational consortium study. Diabetes Care 44:2107\u20132114. https:\/\/doi.org\/10.2337\/dc21-0476","journal-title":"Diabetes Care"},{"key":"2710_CR36","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.clinthera.2021.04.003","volume":"43","author":"IN Petropoulos","year":"2021","unstructured":"Petropoulos IN, Ponirakis G, Ferdousi M, Azmi S, Kalteniece A, Khan A et al (2021) Corneal confocal microscopy: a biomarker for diabetic peripheral neuropathy. Clin Ther 43:1457\u20131475. https:\/\/doi.org\/10.1016\/j.clinthera.2021.04.003","journal-title":"Clin Ther"},{"key":"2710_CR37","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s00125-013-2942-9","volume":"56","author":"R Pop-Busui","year":"2013","unstructured":"Pop-Busui R, Stevens MJ, Raffel DM, White EA, Mehta M, Plunkett CD et al (2013) Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomised controlled trial. Diabetologia 56:1835\u20131844. https:\/\/doi.org\/10.1007\/s00125-013-2942-9","journal-title":"Diabetologia"},{"key":"2710_CR38","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1093\/brain\/aws097","volume":"135","author":"SK Roy Chowdhury","year":"2012","unstructured":"Roy Chowdhury SK, Smith DR, Saleh A, Schapansky J, Marquez A, Gomes S et al (2012) Impaired adenosine monophosphate-activated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes. Brain 135:1751\u20131766. https:\/\/doi.org\/10.1093\/brain\/aws097","journal-title":"Brain"},{"key":"2710_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.921942","volume":"13","author":"AE Rumora","year":"2022","unstructured":"Rumora AE, Guo K, Hinder LM, O\u2019Brien PD, Hayes JM, Hur J et al (2022) A high-fat diet disrupts nerve lipids and mitochondrial function in murine models of neuropathy. Front Physiol 13:921942. https:\/\/doi.org\/10.3389\/fphys.2022.921942","journal-title":"Front Physiol"},{"key":"2710_CR40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fnins.2018.00402","volume":"12","author":"MG Sabbir","year":"2018","unstructured":"Sabbir MG, Calcutt NA, Fernyhough P (2018) Muscarinic acetylcholine type 1 receptor activity constrains neurite outgrowth by inhibiting microtubule polymerization and mitochondrial trafficking in adult sensory neurons. Front Neurosci 12:402. https:\/\/doi.org\/10.3389\/fnins.2018.00402","journal-title":"Front Neurosci"},{"key":"2710_CR41","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.neuropharm.2018.09.020","volume":"143","author":"MG Sabbir","year":"2018","unstructured":"Sabbir MG, Fernyhough P (2018) Muscarinic receptor antagonists activate ERK-CREB signaling to augment neurite outgrowth of adult sensory neurons. Neuropharmacology 143:268\u2013281. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.020","journal-title":"Neuropharmacology"},{"key":"2710_CR42","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1007\/s12035-020-01900-x","volume":"57","author":"A Saleh","year":"2020","unstructured":"Saleh A, Sabbir MG, Aghanoori MR, Smith DR, Roy Chowdhury SK, Tessler L et al (2020) Muscarinic toxin 7 signals via Ca(2+)\/calmodulin-dependent protein kinase kinase beta to augment mitochondrial function and prevent neurodegeneration. Mol Neurobiol 57:2521\u20132538. https:\/\/doi.org\/10.1007\/s12035-020-01900-x","journal-title":"Mol Neurobiol"},{"key":"2710_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/00912700122010014","volume":"41","author":"G Sathyan","year":"2001","unstructured":"Sathyan G, Hu W, Gupta SK (2001) Lack of effect of food on the pharmacokinetics of an extended-release oxybutynin formulation. J Clin Pharmacol 41:187\u2013192. https:\/\/doi.org\/10.1177\/00912700122010014","journal-title":"J Clin Pharmacol"},{"key":"2710_CR44","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1529-8027.2008.00180.x","volume":"13","author":"JR Singleton","year":"2008","unstructured":"Singleton JR, Bixby B, Russell JW, Feldman EL, Peltier A, Goldstein J et al (2008) The Utah early neuropathy scale: a sensitive clinical scale for early sensory predominant neuropathy. J Peripher Nerv Syst 13:218\u2013227. https:\/\/doi.org\/10.1111\/j.1529-8027.2008.00180.x","journal-title":"J Peripher Nerv Syst"},{"key":"2710_CR45","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1523\/JNEUROSCI.17-02-00646.1997","volume":"17","author":"DS Smith","year":"1997","unstructured":"Smith DS, Skene JH (1997) A transcription-dependent switch controls competence of adult neurons for distinct modes of axon growth. J Neurosci 17:646\u2013658. https:\/\/doi.org\/10.1523\/JNEUROSCI.17-02-00646.1997","journal-title":"J Neurosci"},{"key":"2710_CR46","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/dmrr.1239","volume":"27","author":"V Spallone","year":"2011","unstructured":"Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R et al (2011) Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 27:639\u2013653. https:\/\/doi.org\/10.1002\/dmrr.1239","journal-title":"Diabetes Metab Res Rev"},{"key":"2710_CR47","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1517\/14656560903451682","volume":"10","author":"DR Staskin","year":"2009","unstructured":"Staskin DR, Robinson D (2009) Oxybutynin chloride topical gel: a new formulation of an established antimuscarinic therapy for overactive bladder. Expert Opin Pharmacother 10:3103\u20133111. https:\/\/doi.org\/10.1517\/14656560903451682","journal-title":"Expert Opin Pharmacother"},{"issue":"Suppl 1","key":"2710_CR48","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc13-S011","volume":"36","author":"Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology American Diabetes A","year":"2013","unstructured":"Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology American Diabetes A (2013) Standards of medical care in diabetes\u20132013. Diabetes Care 36(Suppl 1):S11-66. https:\/\/doi.org\/10.2337\/dc13-S011","journal-title":"Diabetes Care"},{"key":"2710_CR49","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2337\/dc10-1303","volume":"33","author":"S Tesfaye","year":"2010","unstructured":"Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P et al (2010) Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33:2285\u20132293. https:\/\/doi.org\/10.2337\/dc10-1303","journal-title":"Diabetes Care"},{"key":"2710_CR50","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/mus.880180603","volume":"18","author":"AI Vinik","year":"1995","unstructured":"Vinik AI, Suwanwalaikorn S, Stansberry KB, Holland MT, McNitt PM, Colen LE (1995) Quantitative measurement of cutaneous perception in diabetic neuropathy. Muscle Nerve 18:574\u2013584. https:\/\/doi.org\/10.1002\/mus.880180603","journal-title":"Muscle Nerve"},{"key":"2710_CR51","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/dia.2005.7.497","volume":"7","author":"EJ Vinik","year":"2005","unstructured":"Vinik EJ, Hayes RP, Oglesby A, Bastyr E, Barlow P, Ford-Molvik SL et al (2005) The development and validation of the Norfolk QOL-DN, a new measure of patients\u2019 perception of the effects of diabetes and diabetic neuropathy. Diabetes Technol Ther 7:497\u2013508. https:\/\/doi.org\/10.1089\/dia.2005.7.497","journal-title":"Diabetes Technol Ther"},{"key":"2710_CR52","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41585-021-00504-x","volume":"18","author":"B Welk","year":"2021","unstructured":"Welk B, Richardson K, Panicker JN (2021) The cognitive effect of anticholinergics for patients with overactive bladder. Nat Rev Urol 18:686\u2013700. https:\/\/doi.org\/10.1038\/s41585-021-00504-x","journal-title":"Nat Rev Urol"},{"key":"2710_CR53","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/bs.irn.2016.03.006","volume":"127","author":"S Yagihashi","year":"2016","unstructured":"Yagihashi S (2016) Glucotoxic mechanisms and related therapeutic approaches. Int Rev Neurobiol 127:121\u2013149. https:\/\/doi.org\/10.1016\/bs.irn.2016.03.006","journal-title":"Int Rev Neurobiol"},{"key":"2710_CR54","doi-asserted-by":"publisher","first-page":"5905891","DOI":"10.1155\/2016\/5905891","volume":"2016","author":"MS Yorek","year":"2016","unstructured":"Yorek MS, Coppey LJ, Shevalye H, Obrosov A, Kardon RH, Yorek MA (2016) Effect of treatment with salsalate, menhaden oil, combination of salsalate and menhaden oil, or resolvin D1 of C57Bl\/6J type 1 diabetic mouse on neuropathic endpoints. J Nutr Metab 2016:5905891. https:\/\/doi.org\/10.1155\/2016\/5905891","journal-title":"J Nutr Metab"},{"key":"2710_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109063","volume":"186","author":"D Ziegler","year":"2022","unstructured":"Ziegler D, Tesfaye S, Spallone V, Gurieva I, Al Kaabi J, Mankovsky B et al (2022) Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: international expert consensus recommendations. Diabetes Res Clin Pract 186:109063. https:\/\/doi.org\/10.1016\/j.diabres.2021.109063","journal-title":"Diabetes Res Clin Pract"},{"key":"2710_CR56","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/bs.irn.2016.03.007","volume":"127","author":"DW Zochodne","year":"2016","unstructured":"Zochodne DW (2016) Sensory neurodegeneration in diabetes: beyond glucotoxicity. Int Rev Neurobiol 127:151\u2013180. https:\/\/doi.org\/10.1016\/bs.irn.2016.03.007","journal-title":"Int Rev Neurobiol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-024-02710-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-024-02710-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-024-02710-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T09:11:06Z","timestamp":1711357866000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-024-02710-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,25]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2710"],"URL":"https:\/\/doi.org\/10.1007\/s00401-024-02710-4","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,25]]},"assertion":[{"value":"15 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NAC and PF are co-founders of, and hold equity in WinSanTor Inc., a company which is developing products related to the research described in this paper. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict-of-interest policies. The other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"60"}}